Zogenix Inc (NASDAQ:ZGNX) Sellers Rose By 1.5% Their Shorts As Of Jun 29, 2018

June 29, 2018 - By Norman Soto

Zogenix, Inc. (NASDAQ:ZGNX) Corporate Logo

Zogenix Inc (NASDAQ:ZGNX) had an increase of its short interest by 1.5%. In June was announced ZGNX’s total 4.37 million short interest by FINRA. The up change of 1.5% from 4.31M shares was reported. Previous ZGNX’s position will need 10 days to restore. It has 461,100 average volume. Zogenix Inc’s short interest float is 15.63%.

Ticker’s shares touched $44.1 during the last trading session after 1.97% change.Zogenix, Inc. has volume of 402,807 shares. Since June 29, 2017 ZGNX has risen 225.58% and is uptrending. The stock outperformed the S&P 500 by 213.01%.

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States.The firm is worth $1.55 billion. The companyÂ’s lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome.Currently it has negative earnings. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older.

There’s a significant Zogenix, Inc. (NASDAQ:ZGNX) news brought out by Investorplace.com. It’s an article titled: “Here’s the Reason that GWPH Stock Tumbled Despite Regulatory Victory” on June 27, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: